NCT01350232: Treatment of Sickle Cell Anemia With Stem Cell Transplant |
|
|
| Terminated | N/A | 2 | US | Fludarabine, Fludara, Cytarabine, Ara-C, Cytosar, Cytosine arabinoside, Cellular Infusions, Stem Cells, DLI, HPCT, Total Body Irradiation, TBI, Cyclophosphamide, Cytoxan, Bortezomib, Velcade, Rituximab, Rituxan, Plasmapheresis, Plasma exchange | Sidney Kimmel Cancer Center at Thomas Jefferson University, National Heart, Lung, and Blood Institute (NHLBI) | Sickle Cell Anemia, Sickle Cell-hemoglobin C Disease, Sickle Cell-β0-thalassemia | 08/11 | 08/11 | | |
